Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: A double- blind randomized multicentre trial with renographic assessment

British Journal of Surgery

Volumn 84, Issue 8, 1997, Pages 1099-1103

  Bergqvist, D ^a  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN;

ABDOMINAL CANCER; ADULT; AGED; ARTICLE; BLEEDING; CHEMOPROPHYLAXIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PELVIS CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ABDOMINAL NEOPLASMS; ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD LOSS, SURGICAL; DOUBLE-BLIND METHOD; ENOXAPARIN; FEMALE; HEPARIN; HUMANS; MALE; MIDDLE AGED; PELVIC NEOPLASMS; PHLEBOGRAPHY; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, ELECTIVE; SURVIVAL RATE; THROMBOEMBOLISM; THROMBOPHLEBITIS; TREATMENT OUTCOME;

EID: 0030751133     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840817     Document Type: Article

References (22)

1. Nicolaides A, Arcelus J, Belcaro G et al. Prevention of venous thromboembolism. European Consensus Statement. Int Angiol 1992; 11: 151-9.
2. Bick RL. Coagulation abnormalities in malignancy: a review. Semin Thromb Hemost 1992; 18: 353-72.
3. Nordström M, Lindblad B, Anderson H, Bergqvist D, Kjellström T. Deep venous thrombosis and occult malignancy: an epidemiological study. BMJ 1994; 308: 891-4.
4. Bergqvist D. Review of clinical trials of low molecular weight heparins. Eur J Surg 1992; 158: 67-78.
5. Nurmohamed MT, Rosendaal FR, Büller RH et al. Low-molecular weight heparin versus standard heparin in general and orthopaedic surgery: a meta-analysis. Lancet 1992; 340: 152-6.
6. Leizorowicz A, Haugh MC, Chapuis F-R, Samama MM, Boissel J-P. Low molecular weight heparin in prevention of perioperative thrombosis. BMJ 1992; 305: 913-20.
7. Jørgensen LN, Wille-Jørgensen P, Hauch O. Prophylaxis of postoperative thromboembolism with low molecular weight heparins. Br J Surg 1993; 80: 689-704.
8. Bergqvist D, Burmark US, Flordal PA et al. Low molecular weight heparin started before surgery as prophylaxis against deep vein thrombosis: 2500 versus 5000 XaI units in 2070 patients. Br J Surg 1995; 82: 496-501.
9. Nurmohamed MT, Verhaege R, Haas S et al. A comparative trial of a low molecular weight heparin (enoxaparin) versus standard heparin for the prophylaxis of postoperative deep vein thrombosis in general surgery. Am J Surg 1995; 169: 567-71.
10. Planes A, Vochelle N, Mazas F et al. Prevention of post-operative venous thrombosis: a randomized trial comparing unfractionated heparin with low molecular weight heparin in patients undergoing total hip replacement. Thromb Haemost 1988; 60: 407-10.
11. Turpie AGG, Levine MN, Hirsh J et al. A randomized controlled trial of a low-molecular-weight heparin (enoxaparin) to prevent deep-vein thrombosis in patients undergoing elective hip surgery. N Engl J Med 1986; 315: 925-59.
12. Spiro TE, Johnson GJ, Christie MJ et al. for the Enoxaparin Clinical Trial Group. Efficacy and safety of enoxaparin to prevent deep venous thrombosis after hip replacement surgery. Ann Intern Med 1994; 121: 81-9.
13. Food and Drug Administration. Costart Dictionary. Edition: National Technical Information Service. 3rd ed. Rockville, Maryland: Food and Drug Administration, 1989.
14. Agnelli G, Volpato R, Radicchia S et al. Detection of asymptomatic deep vein thrombosis by real-time B-mode ultrasonography in hip surgery patients. Thromb Haemostat 1992; 68: 257-60.
15. Wells PS, Lensing AWA, Davidson BL, Prins MH, Hirsh J. Accuracy of ultrasound for the diagnosis of deep venous thrombosis in asymptomatic patients after orthopedic surgery. A meta-analysis. Ann Intern Med 1995; 122: 47-53.
16. Mannucci PM, Cugno M, Bottaso B. Hemostatic changes are present in the early stages of solid tumours. Int Med 1993; 1: 45-8.
17. McLeod R, Geerts W, Sniderman K et al. Thromboprophylaxis in colorectal surgery - a randomized trial comparing low dose heparin to enoxaparin. Haemostasis 1996; 26(Suppl 3): 290 (Abstract).
18. Wiig JN, Solhaug JH, Bilberg T et al. Prophylaxis of venographically diagnosed deep vein thrombosis in gastrointestinal surgery. Multicentre trials 20 mg and 40 mg enoxaparin versus dextran. Eur J Surg 1995; 161: 663-8.
19. Scurr JH, Coleridge-Smith PD, Hasty JH. Deep venous thrombosis: a continuing problem. BMJ 1988; 297: 28.
20. Planes A, Vochelle N, Darmon JY, Fagola M, Belland M, Huet Y. Risk of deep-venous thrombosis after hospital discharge in patients having undergone total hip replacement; double-blind randomized comparison of enoxaparin versus placebo. Lancet 1996; 348: 224-8.
21. Bergqvist D, Benoni G, Björgell O et al. Low-molecular-weight heparin (enoxaparin) as prophylaxis against venous thromboembolism after total hip replacement. N Engl J Med 1996; 335: 696-700.
22. Kakkar VV, Cohen AT, Edmonson RA et al. Low molecular weight versus standard heparin for prevention of venous thromboembolism after major abdominal surgery. The Thromboprophylaxis Collaborative Group. Lancet 1993; 341: 259-65.